Wei Rui

961 total citations
8 papers, 754 citations indexed

About

Wei Rui is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Wei Rui has authored 8 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Wei Rui's work include CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (2 papers). Wei Rui is often cited by papers focused on CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (2 papers). Wei Rui collaborates with scholars based in China, United States and Italy. Wei Rui's co-authors include Xin Lin, Xueqiang Zhao, Guangna Liu, Daosheng Huang, Hongli Zheng, Fei Yu, Jiahong Dong, Yuewei Zhang, Lemei Jia and Song Lin and has published in prestigious journals such as Nature Communications, Nature Immunology and Neuroscience.

In The Last Decade

Wei Rui

8 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei Rui China	8	433	272	223	174	119	8	754
Kyle Dyson United States	11	425 1.0×	227 0.8×	296 1.3×	220 1.3×	113 0.9×	19	796
Christopher DeRenzo United States	12	541 1.2×	172 0.6×	249 1.1×	172 1.0×	122 1.0×	24	638
Carter M. Suryadevara United States	16	754 1.7×	224 0.8×	411 1.8×	292 1.7×	171 1.4×	31	1.0k
Jesse Kresak United States	10	382 0.9×	143 0.5×	262 1.2×	110 0.6×	86 0.7×	39	762
Xuekai Zhu China	12	489 1.1×	262 1.0×	247 1.1×	174 1.0×	85 0.7×	23	723
Ekaterina Friebel Switzerland	8	358 0.8×	272 1.0×	594 2.7×	110 0.6×	69 0.6×	11	987
Sarah Wright United Kingdom	10	274 0.6×	171 0.6×	106 0.5×	121 0.7×	126 1.1×	30	627
Filippo Rossignoli United States	11	187 0.4×	221 0.8×	145 0.7×	82 0.5×	73 0.6×	18	582
Axel Hyrenius‐Wittsten Sweden	7	277 0.6×	249 0.9×	117 0.5×	124 0.7×	70 0.6×	11	621

Countries citing papers authored by Wei Rui

Since Specialization

Citations

This map shows the geographic impact of Wei Rui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Rui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Rui more than expected).

Fields of papers citing papers by Wei Rui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Rui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Rui. The network helps show where Wei Rui may publish in the future.

Co-authorship network of co-authors of Wei Rui

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Rui. A scholar is included among the top collaborators of Wei Rui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Rui. Wei Rui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Huang, Daosheng, Yi Li, Wei Rui, et al.. (2024). TCR-mimicking STAR conveys superior sensitivity over CAR in targeting tumors with low-density neoantigens. Cell Reports. 43(11). 114949–114949. 11 indexed citations

2.

Zhang, Xian, Yue Liu, Yu Li, et al.. (2022). A novel adoptive synthetic TCR and antigen receptor (STAR) T‐Cell therapy for B‐Cell acute lymphoblastic leukemia. American Journal of Hematology. 97(8). 992–1004. 27 indexed citations

3.

Liu, Yue, Guangna Liu, Lemei Jia, et al.. (2021). Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors. Science Translational Medicine. 13(586). 113 indexed citations

4.

Liu, Guangna, Wei Rui, Xueqiang Zhao, & Xin Lin. (2021). Enhancing CAR-T cell efficacy in solid tumors by targeting the tumor microenvironment. Cellular and Molecular Immunology. 18(5). 1085–1095. 161 indexed citations

5.

Liu, Guangna, Wei Rui, Hongli Zheng, et al.. (2020). CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma. European Journal of Immunology. 50(5). 712–724. 158 indexed citations

6.

Xu, Xia, Jin‐Fu Xu, Guoxing Zheng, et al.. (2018). CARD9S12N facilitates the production of IL-5 by alveolar macrophages for the induction of type 2 immune responses. Nature Immunology. 19(6). 547–560. 58 indexed citations

7.

Wu, Ze, Lichong Yan, Lei Cao, et al.. (2018). Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumours. Nature Communications. 9(1). 4624–4624. 111 indexed citations

8.

Marconi, Silvia, Ilaria Scambi, Giovanna Squintani, et al.. (2013). Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model. Neuroscience. 248. 333–343. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact